Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Most users report noticeable improvements within 7 to 14 days when using injectable BPC-157 at doses between 0.25mg and 0.5mg daily
Specific target conditions of BCP 157 include muscle injury, allergies, autoimmune disease, fibromyalgia, diabetes, IBD (ulcerative colitis/Crohns), IBS
Research Applications Lipolysis Mechanism Investigation AOD9604 serves as a research tool for investigating 3-adrenergic-receptor-dependent lipolytic pathways: Hormone-Sensitive Lipase: Examination of HSL activation, phosphorylation status, and lipid droplet association ATGL Regulation: Research on adipose triglyceride lipase expression and activity modulation Perilipin Phosphorylation: Investigation of lipid droplet coating protein regulation 3-Adrenergic Receptor Dependence: Studies indicating AOD9604s lipolytic effect requires functional 3-adrenergic receptors (abolished in 3-AR knockout models) and is associated with increased 3-AR expression Signaling Cascades: Examination of kinase cascades, calcium signaling, and downstream effectors Research protocols investigate how AOD9604 stimulates lipolysis through mechanisms distinct from catecholamines, providing insights into alternative fat mobilization pathways
Clinical reports document taste alterations and xerostomia in patients using semaglutide 47 , with studies implicating GLP-1R expression in mammalian taste buds and their role in modulating gustatory sensitivity 48
Standard dispatch is next business day on orders received before the daily cut-off
Formulated with 0.9% benzyl alcohol as a preservative, it is designed to help maintain sterility after initial vial entry, making it suitable for multi-use research applications under controlled conditions
US$ 20.51
US$ 20.36
US$ 26.84